Allergenis

About:

Allergenis is a develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose food allergy.

Website: https://www.allergenis.com/

Top Investors: Corporate Fuel

Description:

AllerGenis is a predictive data analytics company specializing in the detection and management of life-threatening immune response disorders including food allergy. Amassing the world’s largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes to gain clinical insights, AllerGenis is leading the field in developing precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. The company was founded via a collaboration with Hugh Sampson MD, of the Icahn School of Medicine at Mount Sinai. AllerGenis owns and operates a CLIA-certified laboratory in Hatfield, Pennsylvania.